194 related articles for article (PubMed ID: 10840275)
1. beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury.
Horsburgh K; Cole GM; Yang F; Savage MJ; Greenberg BD; Gentleman SM; Graham DI; Nicoll JA
Neuropathol Appl Neurobiol; 2000 Apr; 26(2):124-32. PubMed ID: 10840275
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.
McNamara MJ; Gomez-Isla T; Hyman BT
Arch Neurol; 1998 Jul; 55(7):1001-4. PubMed ID: 9678319
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly.
Walker LC; Pahnke J; Madauss M; Vogelgesang S; Pahnke A; Herbst EW; Stausske D; Walther R; Kessler C; Warzok RW
Acta Neuropathol; 2000 Jul; 100(1):36-42. PubMed ID: 10912918
[TBL] [Abstract][Full Text] [Related]
4. Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.
Mann DM; Iwatsubo T; Pickering-Brown SM; Owen F; Saido TC; Perry RH
Neurosci Lett; 1997 Jan; 221(2-3):81-4. PubMed ID: 9121705
[TBL] [Abstract][Full Text] [Related]
5. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
7. Inconstant apolipoprotein E (ApoE)-like immunoreactivity in amyloid beta protein deposits: relationship with APOE genotype in aging brain and Alzheimer's disease.
Uchihara T; Duyckaerts C; Lazarini F; Mokhtari K; Seilhean D; Amouyel P; Hauw JJ
Acta Neuropathol; 1996 Aug; 92(2):180-5. PubMed ID: 8841664
[TBL] [Abstract][Full Text] [Related]
8. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
10. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.
Levites Y; Das P; Price RW; Rochette MJ; Kostura LA; McGowan EM; Murphy MP; Golde TE
J Clin Invest; 2006 Jan; 116(1):193-201. PubMed ID: 16341263
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta protein deposition in patients with frontotemporal lobar degeneration: relationship to age and apolipoprotein E genotype.
Mann DM; McDonagh AM; Pickering-Brown SM; Kowa H; Iwatsubo T
Neurosci Lett; 2001 May; 304(3):161-4. PubMed ID: 11343827
[TBL] [Abstract][Full Text] [Related]
12. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
13. Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.
Beach TG; Maarouf CL; Intorcia A; Sue LI; Serrano GE; Lu M; Joshi A; Pontecorvo MJ; Roher AE
J Alzheimers Dis; 2018; 61(4):1509-1516. PubMed ID: 29376867
[TBL] [Abstract][Full Text] [Related]
14. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
Ishii K; Lippa C; Tomiyama T; Miyatake F; Ozawa K; Tamaoka A; Hasegawa T; Fraser PE; Shoji S; Nee LE; Pollen DA; St George-Hyslop PH; Ii K; Ohtake T; Kalaria RN; Rossor MN; Lantos PL; Cairns NJ; Farrer LA; Mori H
Neurobiol Aging; 2001; 22(3):367-76. PubMed ID: 11378241
[TBL] [Abstract][Full Text] [Related]
15. Age-related plaque morphology and C-terminal heterogeneity of amyloid beta in Dutch-type hereditary cerebral hemorrhage with amyloidosis.
Maat-Schieman ML; Yamaguchi H; van Duinen SG; Natté R; Roos RA
Acta Neuropathol; 2000 Apr; 99(4):409-19. PubMed ID: 10787040
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
Cho HS; Hyman BT; Greenberg SM; Rebeck GW
J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
[TBL] [Abstract][Full Text] [Related]
17. Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue.
Howlett DR; Hortobágyi T; Francis PT
Brain Pathol; 2013 Nov; 23(6):623-32. PubMed ID: 23521156
[TBL] [Abstract][Full Text] [Related]
18. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.
Mehta PD; Pirttilä T; Mehta SP; Sersen EA; Aisen PS; Wisniewski HM
Arch Neurol; 2000 Jan; 57(1):100-5. PubMed ID: 10634455
[TBL] [Abstract][Full Text] [Related]
19. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.
Yamaguchi H; Sugihara S; Ogawa A; Oshima N; Ihara Y
J Neuropathol Exp Neurol; 2001 Jul; 60(7):731-9. PubMed ID: 11444802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
